欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/5154/001
药品名称
Nevirapine Sandoz
活性成分
NEVIRAPINE ANHYDRATE 200.0 mg
剂型
Tablet
上市许可持有人
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE The Netherlands From PT/0555/001
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Malta (MT)
Germany (DE)
Nevirapin Hetero 200 mg Tabletten
United Kingdom (Northern Ireland) (XI)
许可日期
2012/01/27
最近更新日期
2024/12/03
药物ATC编码
J05AG01 nevirapine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_pl_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean
Date of last change:2024/09/06
Final Product Information
|
DAY30AR_PTH0555001IB007
Date of last change:2024/09/06
PubAR
|
200430 NL_H_5154_001_DC Nevirapine Sandoz PAR
Date of last change:2024/09/06
Final PL
|
patient_information_leaflet_for_variation_ib017g_validation
Date of last change:2024/09/06
Final SPC
|
summary_of_product_characteristics_for_variation_ib017g_vali
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase